Biosynthesis of Galactan in Mycobacterium tuberculosis as a Viable TB Drug Target?

While target-based drug design has proved successful in several therapeutic areas, this approach has not yet provided compelling outcomes in the field of antibacterial agents. This statement remains especially true for the development of novel therapeutic interventions against tuberculosis, an infec...

Descripción completa

Detalles Bibliográficos
Autores principales: Konyariková, Zuzana, Savková, Karin, Kozmon, Stanislav, Mikušová, Katarína
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168186/
https://www.ncbi.nlm.nih.gov/pubmed/31935842
http://dx.doi.org/10.3390/antibiotics9010020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168186/
https://www.ncbi.nlm.nih.gov/pubmed/31935842
http://dx.doi.org/10.3390/antibiotics9010020

Ejemplares similares